🇺🇸 FDA
Pipeline program

Ramelteon

01-04-TL-375-045

Approved small_molecule completed

Quick answer

Ramelteon for Circadian Dysregulation is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Circadian Dysregulation
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials